PIL 0.00% 0.0¢ promisia integrative limited

Ann: S/HOLDER: PIL: Share Purchase Plan Date Corr

  1. lightbulb Created with Sketch. 2
    • Release Date: 15/04/14 13:29
    • Summary: S/HOLDER: PIL: Share Purchase Plan Date Correction
    • Price Sensitive: No
    • Download Document  2KB
    					PIL
    15/04/2014 11:29
    S/HOLDER
    
    REL: 1129 HRS Promisia Integrative Limited
    
    S/HOLDER: PIL: Share Purchase Plan Date Correction
    
    Share Purchase Plan Correction
    
    On April 11th, Promisia Integrative Limited (formerly Savoy Equities
    Limited), announced that it had lodged an application with NZX for a share
    purchase plan with a record date of 24 April 2014.
    
    Unfortunately, the incorrect date was misquoted in the announcement for the
    deadline date by which the offer to Promisia Integrative Limited New Zealand
    Resident shareholders would be recorded on the Company's share register.
    
    The correct date for the deadline should be 5:00pm on 24 April 2014 as
    opposed to the 15th of April.
    
    The correct date was however used for the attachment and the Appendix 7
    application form.
    
    Promisia Integrative Limited is seeking to raise up to $2.8 million from the
    Share purchase Plan, but may at the discretion of the Promisia Integrative
    Limited Board, elect to accept subscriptions received in excess of this
    amount.
    
    The maximum application is $15,000 per New Zealand resident shareholder with
    a minimum application amount of $1,000. Eligible shareholders may apply for
    intermediate amounts of $2,000, $5,000 and $10,000 between the minimum and
    maximum subscription amounts.
    
    The issue price for the shares issued pursuant to the Share Purchase Plan
    will be 4.08 cents per share.
    
    Funds raised from the SPP will be used for a variety of working capital and
    investment purposes including conducting  validated laboratory studies,
    undertaking human clinical trials, development of new formulations and
    products, planting more crops, advertising and promotion, compliance with
    international regulatory requirements, including those of the Federal Drug
    Administration (FDA), and supporting intellectual property claims and
    associated legal costs
    
    For further information please contact:
    
    Mr. Charles Daily, Chief Executive Officer on (04) 889 0234
    or
    Mr. Malcolm Johnson, Chairman on (04) 479 3377
    End CA:00249500 For:PIL    Type:S/HOLDER   Time:2014-04-15 11:29:04
    				
 
watchlist Created with Sketch. Add PIL (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.